Bortezomib

Quote:Email inquiry(Click to send)
Bortezomib

CAS:179324-69-7
Molecular Formula:C19H25BN4O4
Molecular Weight:384.237 g/mol
Product description:Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsedmultiple myeloma and mantle cell lymphoma.

Please feel free to contact us  for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales

Promotion,New Products,And any other assistance.

Bolise Co., LimitedAfter send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.

1. Email: sales@aushealthingredients.com
2. Tel: +86 592 536 5868
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: